ibudilast ophthalmic solution is indicated for the treatment of allergic conjunctivitis and hay fever it may have some use reducing methamphetamine and alcohol addiction ibudilast has bronchodilator vasodilator and neuroprotective effects and is mainly used in the treatment of asthma and stroke it inhibits platelet aggregation and may also be useful in the treatment of multiple sclerosis ibudilast crosses the blood brain barrier and suppresses glial cell activation this activity has been shown to make ibudilast useful in the treatment of neuropathic pain and it not only enhances analgesia produced by opioid drugs but also reduces the development of tolerance ibudilast is principally a pde4 inhibitor but has also been shown to act as an antagonist at the toll like receptor 4 tlr4 this likely plays a large part in its effect specifically its synergy with opioid drugs its anti inflammatory effect and its own painkilling effect it is unknown if the pde4 inhibiting properties potentiate the effects of tlr4 inactivation and or vice versa despite that some of their effects are shared such as inflammation reducing properties tlr4 antagonists theoretically reverse the increase in pain and inflammation caused by most tlr4 agonists which include many opiate and opioid drugs